<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>H4C Net &#187; Cancer Treatment</title>
	<atom:link href="http://www.h4c.net/category/cancer-treatment/feed" rel="self" type="application/rss+xml" />
	<link>http://www.h4c.net</link>
	<description>Health 4 Care Resources</description>
	<lastBuildDate>Wed, 05 May 2010 03:23:29 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.0.5</generator>
		<item>
		<title>Sandostatin LAR Depot Controls Rare Gastrointestinal Tumor Growth</title>
		<link>http://www.h4c.net/cancer-treatment/sandostatin-lar-depot-controls-rare-gastrointestinal-tumor-growth.html</link>
		<comments>http://www.h4c.net/cancer-treatment/sandostatin-lar-depot-controls-rare-gastrointestinal-tumor-growth.html#comments</comments>
		<pubDate>Mon, 19 Jan 2009 16:05:08 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Cancer Treatment]]></category>
		<category><![CDATA[Health]]></category>

		<guid isPermaLink="false">http://localhost/health/?p=14497</guid>
		<description><![CDATA[Sandostatin LAR Depot (octreotide acetate suspension for injection) demonstrated antitumor benefit in patients with metastatic neuroendocrine tumors (NETs) of the midgut, according to interim data presented today at the 2009 Gastrointestinal Cancer Symposium of the American Society of Clinical Oncology. After six months of treatment, patients receiving Sandostatin LAR had a 66% reduction in risk [...]]]></description>
		<wfw:commentRss>http://www.h4c.net/cancer-treatment/sandostatin-lar-depot-controls-rare-gastrointestinal-tumor-growth.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>RAD001 Trial Results Positive In Patients With Advanced Gastric Cancer</title>
		<link>http://www.h4c.net/cancer-treatment/rad001-trial-results-positive-in-patients-with-advanced-gastric-cancer.html</link>
		<comments>http://www.h4c.net/cancer-treatment/rad001-trial-results-positive-in-patients-with-advanced-gastric-cancer.html#comments</comments>
		<pubDate>Mon, 19 Jan 2009 16:05:04 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Cancer Treatment]]></category>
		<category><![CDATA[Diet]]></category>

		<guid isPermaLink="false">http://localhost/health/?p=14496</guid>
		<description><![CDATA[Data show RAD001 (also known as everolimus; proposed brand name Afinitor) halted tumor growth in 55% of patients with advanced gastric cancer, a condition for which there are limited treatment options. In addition, 45% of patients in the study demonstrated some tumor shrinkage. The data will be presented at the American Society of Clinical Oncology&#8217;s [...]]]></description>
		<wfw:commentRss>http://www.h4c.net/cancer-treatment/rad001-trial-results-positive-in-patients-with-advanced-gastric-cancer.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Oral Xeloda Plus Oxaliplatin Is Comparable To FOLFOX As Colorectal Cancer Treatment</title>
		<link>http://www.h4c.net/cancer-treatment/colon-cancer-symptoms-and-treatment/oral-xeloda-plus-oxaliplatin-is-comparable-to-folfox-as-colorectal-cancer-treatment.html</link>
		<comments>http://www.h4c.net/cancer-treatment/colon-cancer-symptoms-and-treatment/oral-xeloda-plus-oxaliplatin-is-comparable-to-folfox-as-colorectal-cancer-treatment.html#comments</comments>
		<pubDate>Mon, 19 Jan 2009 16:05:02 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Colon Cancer Symptoms and Treatment]]></category>

		<guid isPermaLink="false">http://localhost/health/?p=14495</guid>
		<description><![CDATA[Overall survival results from a 14-month follow-up of the international, Phase III NO16966 study confirm that oral Xeloda plus oxaliplatin (XELOX) is comparable to a current standard treatment, FOLFOX-4 (infused 5-FU/leucovorin plus oxaliplatin) in the first-line treatment of advanced (metastatic) colorectal cancer. In the study, patients receiving XELOX lived for a median of 19.0 months, [...]]]></description>
		<wfw:commentRss>http://www.h4c.net/cancer-treatment/colon-cancer-symptoms-and-treatment/oral-xeloda-plus-oxaliplatin-is-comparable-to-folfox-as-colorectal-cancer-treatment.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Abnormal DNA repair genes may predict pancreatic cancer risk</title>
		<link>http://www.h4c.net/cancer-treatment/abnormal-dna-repair-genes-may-predict-pancreatic-cancer-risk.html</link>
		<comments>http://www.h4c.net/cancer-treatment/abnormal-dna-repair-genes-may-predict-pancreatic-cancer-risk.html#comments</comments>
		<pubDate>Mon, 19 Jan 2009 16:01:33 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Cancer Treatment]]></category>
		<category><![CDATA[Health]]></category>

		<guid isPermaLink="false">http://localhost/health/?p=14412</guid>
		<description><![CDATA[Abnormalities in genes that repair mistakes in DNA replication may help identify people who are at high risk of developing pancreatic cancer, a research team from The University of Texas M. D. Anderson Cancer Center reports in the Jan. 15 issue of Clinical Cancer Research. Defects in these critical DNA repair genes may act alone [...]]]></description>
		<wfw:commentRss>http://www.h4c.net/cancer-treatment/abnormal-dna-repair-genes-may-predict-pancreatic-cancer-risk.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Teenage Immigrant Survived Cancer, Built A New Life</title>
		<link>http://www.h4c.net/cancer-treatment/teenage-immigrant-survived-cancer-built-a-new-life.html</link>
		<comments>http://www.h4c.net/cancer-treatment/teenage-immigrant-survived-cancer-built-a-new-life.html#comments</comments>
		<pubDate>Mon, 19 Jan 2009 16:01:12 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Cancer Treatment]]></category>
		<category><![CDATA[Health]]></category>

		<guid isPermaLink="false">http://localhost/health/?p=14402</guid>
		<description><![CDATA[No one who survives life-threatening cancer emerges from that dark tunnel the same person who entered. In her new memoir, &#8220;It Gets Better!&#8221;, Maria Machado Munroe draws together her experiences as a teenage cancer patient and her struggles and joys in building a new life for herself. By telling her story in clear and powerful [...]]]></description>
		<wfw:commentRss>http://www.h4c.net/cancer-treatment/teenage-immigrant-survived-cancer-built-a-new-life.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

